Estrogen Receptor Antagonist [EPC]: Side Effects & Safety Data for 2 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Estrogen Receptor Antagonist [EPC] includes 2 drugs with a combined 24,610 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
2
Drugs in Class
24,610
Combined Reports
All Estrogen Receptor Antagonist [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| FULVESTRANT | FULVESTRANT | 17,675 | 3,087 | 4,103 | 17.5% |
| ELACESTRANT | ORSERDU | 6,935 | 525 | 843 | 7.6% |
Common Side Effects in Estrogen Receptor Antagonist [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Malignant neoplasm progression | 3,349 | 488 |
| Nausea | 2,964 | 239 |
| Fatigue | 2,921 | 196 |
| Death | 2,176 | 2,175 |
| Diarrhoea | 1,703 | 104 |
| Metastases to bone | 1,576 | 97 |
| Disease progression | 1,498 | 117 |
| Neutropenia | 1,492 | 141 |
| Vomiting | 1,476 | 182 |
| Metastases to liver | 1,292 | 179 |